GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (NAS:PRQR) » Definitions » Long-Term Debt

ProQR Therapeutics NV (ProQR Therapeutics NV) Long-Term Debt : $4.68 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is ProQR Therapeutics NV Long-Term Debt?

ProQR Therapeutics NV's Long-Term Debt for the quarter that ended in Dec. 2023 was $4.68 Mil.

ProQR Therapeutics NV's quarterly Long-Term Debt declined from Jun. 2023 ($3.87 Mil) to Sep. 2023 ($3.09 Mil) but then increased from Sep. 2023 ($3.09 Mil) to Dec. 2023 ($4.68 Mil).

ProQR Therapeutics NV's annual Long-Term Debt declined from Dec. 2021 ($44.43 Mil) to Dec. 2022 ($4.52 Mil) but then increased from Dec. 2022 ($4.52 Mil) to Dec. 2023 ($4.68 Mil).

ProQR Therapeutics NV Long-Term Debt Historical Data

The historical data trend for ProQR Therapeutics NV's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProQR Therapeutics NV Long-Term Debt Chart

ProQR Therapeutics NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.12 19.70 44.43 4.52 4.68

ProQR Therapeutics NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.52 4.18 3.87 3.09 4.68

ProQR Therapeutics NV  (NAS:PRQR) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

ProQR Therapeutics NV Long-Term Debt Related Terms

Thank you for viewing the detailed overview of ProQR Therapeutics NV's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ProQR Therapeutics NV (ProQR Therapeutics NV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (NAS:PRQR) » Definitions » Long-Term Debt
Comparable Companies
PRLD MNOV CDXC ANIX GMDA NKTX INO IFRX VXRT ABEO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
0PQ:Germany
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
Website
https://www.proqr.com
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.